Related Experiment Video
Updated: Jul 2, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Does consideration of Medicare use affect VA evaluations of treatment for new episodes of depression?
John F McCarthy1, Kara Zivin, Karen L Austin
1HSR&D Field Program, VA Serious Mental Illness Treatment Research and Evaluation Center, PO Box 130170, Ann Arbor, MI 48113-0170, USA. john.mccarthy2@va.gov
Abstract:
This report evaluates whether consideration of out-of-system use affects Veterans Affairs (VA) health system assessments of depression treatment. We measured effective medication management and optimal practitioner contacts among veterans whose VA data indicated a new episode of depression. Among 3,567 VA patients who were Medicare age-eligible, VA data indicated that 69% received recommended antidepressant coverage and 9% received recommended practitioner contacts. After including Medicare data, 295 patients (8%) no longer met inclusion criteria. Among the remainder, 3% received Medicare depression treatment and 0.5% were re-classified as having recommended contacts. Medicare use does not substantially supplement VA depression treatment.
Related Concept Videos
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: MAOIs and Other Agents
Therapeutic Drug Monitoring: Affecting Factors
Antidepressant Drugs: Overview
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...
